Skip to main content

Table 3 Summary of patients who died during the 5 year follow up period

From: Effect of Erythropoietin in patients with acute myocardial infarction: five-year results of the REVIVAL-3 trial

Patient #

Group

Cause of death

1

Placebo

cardiogenic shock

2

Placebo

cardiogenic shock

3

EPO

lung embolism

4

Placebo

sudden cardiac death

5

EPO

septic shock, stroke

6

EPO

cancer

7

Placebo

after orthopedic surgery

8

EPO

sudden cardiac death

9

EPO

unknown

10

Placebo

cancer

11

EPO

sudden cardiac death

12

Placebo

unknown

13

EPO

unknown

14

EPO

unknown

  1. Patient # 1–5 died 1–186 days after randomization. Patient # 7–14 died 187–1860 days after randomization